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The prevalence of autism spectrum disorders (ASD) is 1-2% worldwide, 1 in 68 in the U.S, and unknown in Africa. 
ASD is under-diagnosed in Mali due to stigma and the lack of appropriate human resources and infrastructure. 
Objective: 
To determine the ASD frequency and potential risk factors in Mali. 
Methods: 
We identified all the health facilities and community-based organizations involved in the ASD diagnosis and 
management in Bamako. We established an ASD research and awareness platform in Mali, which encompasses 
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community-based organizations and a multidisciplinary team including psychiatrists, psychologists, pediatricians, 
geneticists, and public health and social science specialists. Through this platform, we performed a survey in health 
facilities and organizations where patients with ASD are likely to seek care in Bamako. We reviewed the psychiatric 
patient registry to obtain basic epidemiological profiles of children with ASD, epilepsy and other psychiatric 
disorders. 
Results: 
We found a health facility-based prevalence of ASD of 4.5% (105/2,343) in Bamako. The mean age at the first 
outpatient visit was 7.64 ± 3.85 years old. First degree consanguinity of 29.5% (31/105) was more frequent in 
parents of ASD children versus age and sex matched controls OR= 4.37 [1.96-9.76] p=0.0001. 
Conclusion: 
Our data suggest that ASD is more common than expected in Mali. The established ASD awareness and research 
platform may improve the diagnosis and management of ASD by raising ASD awareness, training of Malian 
clinicians and researchers in early ASD screening and diagnosis, and strengthening research capacity in genomics 
of ASD and other mental disorders. 
 
INTRODUCTION 
On average 1 in 68 children in the U.S. are diagnosed with autism spectrum disorders (ASD), but significant 
variations in prevalence depending on geographic area, sex, race/ethnicity, and level of intellectual ability 
exist (5). Autistic individuals have impaired reciprocal social interaction and communication, restricted 
repetitive and stereotyped behaviors (17). Girls experience fewer restricted and repetitive behaviors and 
externalizing behavioral problems (34). ASD are clinically classified by the severity of the disorder, language 
level, and the presence of learning disability/mental retardation (20). The onset or the diagnosis can be early 
around three years old or late in adolescence or adulthood (25). Comorbidities such as epilepsy, intellectual 
disability, and tuberous sclerosis are frequent (25, 32). A well-coordinated worldwide effort to identify risk 
factors for ASD and to meet the needs of persons with ASD and their families is needed from the global 
scientific community. Sub Saharan Africa (SSA) can significantly contribute in a unique way to a better 
understanding of the etiology, the genetic and environmental risk factors the influence of cultural 
backgrounds on ASD diagnosis and the preferences of treatment options based on parental perceptions (12, 
16). However, ASD is currently understudied in Africa where its prevalence is unknown. More genetic 
epidemiology studies on ASD are needed in Africa in general and West Africa in particular (3). The University 
of Sciences, Techniques and Technologies of Bamako (USTTB), Mali, has been collaborating with the 
University of California Los Angeles, UCLA, U.S and the University of Cape Town (UCT), South Africa to 
establish an ASD genetic research platform and awareness in Mali for West Africa. Ultimately, such 
collaborative genetic research will lead to a better understanding of the genetics basis of ASD in populations 
with Black African ancestry in West Africa and elsewhere. In Mali, our aims were (i) to describe the 
landscape of ASD diagnosis and management (ii) to determine the health facility-based prevalence of ASD 
(iii) to implement our ASD awareness campaign across the country and (iv)  to identify potential ASD risk 
factors. 
METHODS 
To describe the landscape of ASD and the health facility-based prevalence of ASD in Mali, we identified in 
2014 all the public and private health facilities and organizations involved in the diagnosis and management 
of ASD in Bamako. We reviewed the outpatient medical charts of 12,000 children aged 3-14 years old 
treated at our study sites (the psychiatry department of the University hospital Point G, AMALDEME and 
three private medical clinics (Kaidara, Solidarite and Algi) from 2004 to 2014. We gathered information from 
2,343 medical charts with neuropsychiatric disorders in our study questionnaire. Data were collected mainly 
by three junior investigators (a neuroscientist, a neurologist and a fourth year psychiatry resident) at our 
study sites. The following diagnostic criteria (the Diagnostic and Statistical Manual of Mental Disorders, 
DSM–5 for ASD (1), The International League Against Epilepsy, ILAE official report, 2014 for epilepsy (11) 
and the International Classification of Diseases, ICD-10 for other neuropsychiatric disorders (35)) by 
psychiatrists in the hospital, a neurologist at the private medical clinics Solidarite and Algi and by a neuro-
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paediatrician at the private medical clinic Kaidara) were used in our study. We diagnosed autism spectrum 
disorder (ASD) on the basis of difficulties in two areas – social communication, and restricted, repetitive 
behaviour or interests according to the DSM-5 criteria. ASD cases were female or male children aged 3-14 
years old and controls (epilepsy or other neuropsychiatric disorders) were age and sex matched. We 
selected two controls (one epileptic and one with another neuropsychiatric disorder) for each ASD case for 
risk estimation.” 
The psychiatry department of the teaching hospital Point G was our main study site. A weekly child 
outpatient visit (including autistic children) has now been running for a decade at the psychiatry department 
in Point G. Patients and their families benefit from the free psychological support and weekly music therapy 
(Kotéba national) conducted by the National Institute of Arts of Mali, under supervision of the medical 
psychologist. 
In 2010 and 2013, the first two associations of autistic families were created. 
To determine the health facility-based prevalence of ASD, we also contacted in Bamako every single health 
facility or organization involved in ASD diagnostic, care, awareness seeking collaboration. 
To implement our ASD awareness campaigns, we have done various ASD awareness activities in urban and 
rural Mali. Since 2016, an ASD awareness conference is organized for the international autism day on April 
2
nd
 in Bamako. A 1-day seminary for information and education of parents of autistic children, traditional 
healers and medical doctors is held at the FMOS annually. A survey was conducted to determine the 
baseline knowledge, attitudes and practices (KAP) of Malians on ASD (AAS open, manuscript in review). To 
engage the decision-makers, we presented our ASD research program before the Malian House of 
Representatives in 2017 and the chief of the cabinet of the first Lady of Mali. Private and public media were 
associated heavily involved in our ASD awareness events from the beginning. In rural Mali, we took 
advantage of the existing health information system to reach out to the local population. In 2018, we 
designated the Autism Ambassadors and Animators of Mali whose task was to use their leadership and 
networking to raise the ASD awareness in the general population and among the decision and policy 
makers. 
To identify the potential ASD risk factors, we calculated the odds ratio using the proportion of presence of a 
particular potential ASD risk factor in autistic children as compared to age and sex matched controls with 
either epilepsy or other neuropsychiatric disorders. 
Our data were analyzed using SPSS20. The significance of the p value was set at <0.05. For the OR 
calculation, normal variant or absent of abnormality was used as the reference. 
RESULTS 
The health facility-based prevalence of ASD was 4.5% (105/2,343) in Bamako (Table 1). The male to female 
ratio was 1.5/1. A total of 86.7% (91/105) autistic children were from Bamako and 58.1% (61/105) were 
managed at the psychiatry department of the teaching hospital Point G. Autistic children were unschooled in 
88.6% (93/105) of cases. On average, seven (7) autistic had the first medical visit each year (105 autistic 
children from 2004 to 2014) with the highest rates in 2009 (n=13) and 2012 (n=22) (Table 2). Autistic 
children were born to first degree consanguineous marriage and abnormal pregnancy four times as 
frequently as compared to children with epilepsy OR=4.47 [2.00-9.96] p=0.0002 and OR=4.83 [1.02-
22.91] p=0.006, respectively (Table 3). Autistic children were born to first degree consanguineous marriage 
and a multipara woman (>7 births) with a family history of psychiatric disorder on the paternal side two times 
as frequently as compared to children with epilepsy OR=2.72 [1.35-5.47] p=0.0007, OR=2.38 [1.06–
5.33] p=0.05 and OR= 2.97 [1.11-7.91] p=0.04, respectively (Table 4). 
  




Health facility-based prevalence of ASD in Mali 
In this study, we found 4.5% (105/2,343) autistic children in Mali (Table 1), a good estimation of the 
magnitude of ASD in Mali. In Nigeria, ASD was found to be among the least frequent infantile 
neuropsychiatric disorders with an incidence of 2.3% of 2,320 (2, 18). In one way, this is over-estimated due 
to study participant selection bias in our study sites where clinicians were either a child neurologist, child 
psychiatrist or a neuro-pediatrician. In another way, it may be underestimated because most parents do not 
seek care for their autistic children due to either the stigma surrounding autism or prefer traditional to the 
conventional medicine influenced by either local beliefs and ignorance or the difficult accessibility and 
unaffordability of available mental health services in Bamako. Consequently, the mean age at the first 
outpatient visit in our cohort was 7.64± 3.85 years old in Bamako (Table 2) as compared to the mean age at 
diagnosis of 3 years 10 months in the U.S. and 44.7 (Standard Deviation=21.2) months in Nigeria (18, 29). 
Rural, near-poor children and those with severe language impairment received a diagnosis 0.4 years later 
than urban children; 0.9 years later than those with incomes >100% above the poverty level and 1.2 years 
earlier than other children (29). The presumably delayed diagnosis of ASD in Malian children based on the 
mean age of first medical visit was a real concern. An earlier ASD screening and diagnosis coupled with 
early appropriate psychosocial intervention will definitely lead to a better outcome in Malian autistic children. 
Therefore, the modified checklist for toddlers–Revised/Follow up (M-CHAT-R/F) and the social 
communication questionnaire (SCQ) were validated into the Malian sociocultural context in Bamako in 2017 
(23). 
Autistic children were unschooled in 88.6% (93/105) (Table 2). Special education and behavior therapy are 
rare or absent in our resources limited settings (21, 24). Due to the lack of Applied behavioral analysis (ABA) 
services, atypical antipsychotic risperidone is widely prescribed to autistic children at the psychiatry of Point 
G (personal communication with the head department) to improve various behavioral problems as suggested 
in the literature (13). 
On average, seven autistic had the first medical visit each year (105 autistic children from 2004 to 2014) with 
the peaks in 2009 (n=13) and 2012 (n=22) (Table 2). The peaks coincided with the year of creation of the 
two previous associations of parents of autistic children in Bamako. This suggests the importance of the 
active involvement of autistic parents to the ASD awareness campaigns to promote medical care seeking 
behaviors. 
Potential ASD risk factors in Mali 
From our retrospective study, we found that abnormal pregnancy, consanguinity, family history of psychiatric 
disorders were potential ASD risk factors in Mali. Children born to mothers from abnormal pregnancy OR: 
4.83 [1.02-22.91] p=0.06 and those from consanguineous marriage OR= 4.47 [2.00-9.96] p=0.0002 and 
those had four times were increased risk of being autistic as compared to their age and sex matched peers 
born to normal pregnancy by non-consanguineous couples. Exposures to environmental factors (alcohol, 
tobacco, cannabis, illegal drugs) during pregnancy as possible risk factors for autism have been investigated 
in numerous epidemiological studies with inconsistent results (19). The rate of consanguinity, a marriage 
between cousins or relatives, in the cohort of families with neuropsychiatric disorders ranges from 13% to 
30% in Mali (7, 28, 30). Consanguineous families, with syndromic and non-syndromic autism will be worth 
investigating for the discovery of new recessive ASD genes in Mali. 
When compared with vaginal delivery, either emergency or planned C-section has consistently been 
associated with an increased risk of ASD (4). The Malian government sponsored C-section to make it free all 
over the country in 2009 increasing drastically the C-section rate in the country (9). Consequently, Mali had 
an overall C-section rate in facilities of 31.0% from 2014 to 2016 (6).  Despite such high rate, C-section was 
found in only 5 (4.8%) autistic versus 2 (1.9%) controls OR=2.5 [0.47-13.17] p=0.28 whereas Meguid et 
al., 2018 reported C-section and neonatal jaundice as the most common risk factors of ASD in Egypt (22). 
Our main study site was the psychiatry department. We observed that pediatricians are more likely to inquire 
about C-section in caring for children as compared to psychiatrists. Psychiatrists focus more on the maternal 
mental health (31). 
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A family history of psychiatric disorder (when at least one person from either the maternal or paternal family 
had history of schizophrenia, bipolar disorder (33)) on the paternal side two times OR= 2.97 [1.11-
7.91] p=0.04 (Table 3). Family history of mental illness may be more relevant in adolescent onset psychosis 
and a child is more likely to get a mental illness diagnosis in the presence of family history of psychiatric 
disorder (26). Lagunju et al., reported 22.6% children (n=54) had a positive family history of autism, and 
75.5% had associated neurological comorbidities (18). Besides co-morbidities, overlap between clinical 
manifestations of psychiatric disorders has been described in the literature (10, 28). 
Mothers who had seven or more births were as twice as likely to have autistic children as compared to 
epileptic controls OR=2.38 [1.06–5.33] p=0.05 (Table 4). This could be explained by the advanced maternal 
age at the conception, but we did not gather information on the birth order of the autistic children in their 
respective families. 
Implementation of ASD awareness campaigns in Mali 
The Association Djiguiya in tandem the Autism Ambassadors and Animators of Mali including the ex-Ministry 
of higher education geared up the ASD awareness activities this year. Malian health authorities and 
significant stakeholders are on board to create a center for Autism Research and Training (CART) in Mali. 
The landscape of ASD in Mali 
As a result from describing the landscape of ASD in Mali, a multidisciplinary Malian ASD research team was 
built to generate preliminary data, to consolidate collaboration with foreign institutions such as the University 
of California Los Angeles (UCLA) and the University of Cape Town (UCT). A unified national association of 
parents of autistic children “Association Djguiya” was created in January 2018 to carry out ASD awareness 
activities and support ASD research in Mali. Due to our cultural representation of ASD in sub-Saharan Africa, 
most parents still prefer traditional and spiritual healing, partly due to the lack of appropriate treatment, and 
financial burdens of the conventional medical practice (8, 14, 15, 27). The Kotéba national, a psychotherapy 
technique designed based on the psychodrama of Jacob Levy Moreno (29) will be a good resource 
educating the general Malian population on ASD. 
CONCLUSION 
This study shows a high health facility prevalence of autism and a significant relationship to first degree 
relatives and to a paternal history of psychiatric illness. The important public health implications of these 
findings substantiate the detailed and unique methodology used in this study. This is a new development in 
ASD screening, diagnostic, care and research in Mali. Instead of “the same size fits all” policy for autistic 
children, the standard of ASD diagnosis and care has been raised in Mali far behind the systematic 
prescription of atypical and classic antipsychotic drugs to compensate for the lack of ABA specialists in Mali. 
The association “Djiguiya” took the ASD awareness campaigns with unexpected progress within year 1 of its 
creation. Our collaborative autism genetic research is new and unique in Africa and should inspire ASD and 
mental health researchers in neighboring countries. Our ultimate goal is to embrace the global autism 
awareness to establish a comprehensive autism research and training program in Mali for West Africa. 
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Table 1: Health facility-based prevalence of neuropsychiatric disorders in Bamako, Mali 
Diagnosis Frequency (n=2,343) Percentage (%) 
Undetermined medical diagnosis 839 35.81 
Epilepsy† 661 28.21 
Mental retardation 125 5.33 
Autism 105 4.5 
Hemiplegia 99 4.22 
Acute psychotic disorders 64 2.73 
Schizophrenia 46 1.96 
Mental instability 42 1.79 
Personality disorders 36 1.54 
Structural brain damage‡ 34 1.45 
Anxiety disorders 33 1.41 
Depression 33 1.41 
Language speech disorder 31 1.32 
Symptomatic acute psychosis 31 1.32 
Hysteria 26 1.11 
Encephalopathy 24 1.02 
Movement disorders§ 16 0.68 
Headaches 16 0.68 
Obsessive-compulsive disorder 13 0.54 
Cerebral palsy 10 0.43 
Cannabis use related psychosis 10 0.43 
Down syndrome 10 0.43 
Sleep disorders 9 0.38 
Rett syndrome 8 0.34 
Mental confusion or delirium 7 0.30 
Strabismus /nystagmus 6 0.26 
Bipolar disorders 3 0.13 
Suicide attempts 3 0.13 
Attention deficit hyperactive disorders 3 0.13 
†
West syndrome (n=12), myoclonic seizures (n=5), etc… 
‡
Hydrocephalia (n=8), brain tumor (n=7), 
meningoencephalitis (n=7), brain malformation (n=5), head trauma (n=2), microcephalia (n=2), brain atrophy 
(n=2), hypoplasia (n=1), neurofibromatosis (n=1) 
§
Cerebellar ataxia (n=9), dystonia (n=3), chorea (n=3), 
essential tremor (n=1) 
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Table 2: Socio-demographic information of the autistic children and their matched controls 
Parameters 
Autism 






N= 105 (100%) 
Sex 
Male 63 (60%) 63 (60%) 63 (60%) 
Female 42 (40%) 42 (40%) 42 (40%) 
Age group 
(years old) 
< 4 12 (11.4%) 12 (11.4%) 12 (11.4%) 
4-8 38 (36.2%) 38 (36.2%) 38 (36.2%) 
9-14 55 (62.4%) 55 (62.2%) 55 (62.2%) 
Address 
Bamako 91 (86.7%) 81 (77.1%) 89 (84.8%) 
Provinces (regions) 14 (13.3%) 24 (22.9%) 16 (15.2%) 
Study sites 
Teaching Hospital Point G 61 (58.1%) 10 (9.5%) 52 (49.5%) 
AMALDEME 24 (22.8%) 0 (0%) 1 (1%) 
Private medical clinics 20 (19.1%) 95 (90.5%) 52 (49.5%) 
Education 
None 93 (88.6%) 79 (75.2%) 63 (60%) 
Primary school 12 (11.4%) 23 (21.9%) 40 (38.1%) 
Middle school 0 (0%) 3 (2.9%) 2 (1.9%) 
Year of first 
outpatient 
visit** 
2000 – 2005 3 (3%) 2 (1.9%) 4 (3.8%) 
2006 – 2008 21 (20%) 4 (3.8%) 20 (19.1%) 
2009 13 (12.4%) 5 (4.8%) 13 (12.4%) 
2010 – 2011 19 (18.1%) 38 (36.2%) 25 (23.8%) 
2012 22 (21%) 20 (19.1%) 20 (19.1%) 
2013 – 2015 27 (25.7%) 36 (34.3%) 23 (21.9%) 
*Neuropsychiatric disorders different from autism and epilepsy   **Year of first outpatient visit was the year 
when the patient was seen for the first time at one of our study sites. The mean age of patients at the first 
outpatient visit was 7.64 ± 3.85 years. 
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Table 3: Potential ASD risk factors in autistic versus epileptic children in Mali 











Yes 31 (29.5%) 9 (8.6%) 4.47 [2.00-9.96] p=0.0002 
No 74 (70.5%) 96 (91.4%) 
 
Pregnancy 
Abnormal 9 (8.6%) 2 (1.9%) 4.83 [1.02-22.91] p=0.006 
Normal 96 (91.4%) 103 (98.1%) 
 
Delivery 
C-section 5 (4.8%) 2 (1.9%) 2.5 [0.47-13.17] p=0.28 
labor dystocia 21 (21%) 10 (9.5%) 2.37 [1.06–5.33] p= 0.052 
Normal 79 (75.2%) 93 (88.6%) 
 
Infancy 
Abnormal 32 (30.5%) 30 (28.6%) 1.09 [0.61-1.98] p= 0.88 
Normal 73 (69.5%) 75 (71.4%) 
 
Maternal family 
history of mental 
illness 
Present 13 (12.4%) 8 (7.6%) 1.71 [0.68-4.32] p= 0.36 
Absent 92 (87.6%) 97 (92.4%) 
 
Paternal family 
history of mental 
illness 
Present 16 (15.2%) 14 (13.3%) 1.17 [0.54-2.53] p= 0.84 
Absent 89 (84.8%) 91 (86.7%) 
 
Parity 
Unknown 24 (22.9%) 45 (42.9%) 
 
1-2 14 (13.3%) 9 (8.6%) 1.64 [0.68-3.98] p= 0.38 
3-4 26 (24.7%) 26 (24.7%) 1.00 [0.53-1.87] p= 0.86 
5-6 20 (19.1%) 13 (12.4%) 1.13 [0.56-3.55] p= 0.26 
7-15 21 (21%) 12 (11.4%) 1.77 [0.83–3.75] p=0.20 
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 Table 4: Potential ASD risk factors in autistic versus neuropsychiatric disorders in Mali 
  







(%) n= 105 
Odds ratio (OR) 
p-value 
Consanguinity 
Yes 31 (29.5%) 14 (13.3%) 2.72 [1.35-5.47] p=0.0007 
No 74 (70.5%) 91 (86.7%) 
 
Pregnancy 
Abnormal 9 (8.6%) 4 (3.8%) 2.37 [0.71- 7.94] p=0.25 
Normal 96 (91.4%) 101 (96.2%) 
 
Delivery 
C-section 5 (4.8%) 2 (1.9%) 2.5 [0.47-13.17] p=0.28 
labor 
dystocia 
21 (21%) 16 (15.2%) 1.39 [0.68–2.84] p= 0.47 
Normal 79 (75.2%) 87 (82.9%) 
 
Infancy 
Abnormal 32 (30.5%) 21 (21%) 1.75 [0.93-3.30] p= 0.11 
Normal 73 (69.5%) 84 (79%) 
 
Maternal family 
history of mental 
illness 
Present 13 (12.4%) 7 (6.7%) 1.97 [0.76-5.18] p= 0.24 
Absent 92 (87.6%) 98 (93.3%) 
 
Paternal family history 
of mental illness 
Present 16 (15.2%) 6 (5.7%)  2.97 [1.11-7.91] p= 0.04 
Absent 89 (84.8%) 99 (94.3 %) 
 
 Parity 
Unknown 24 (22.9%) 38 (36.2%) 
 
1-2 14 (13.3%) 23 (21.9%) 0.55 [0.26-1.14] p= 0.15 
3-4 26 (24.7%) 16 (15.2%) 1.83 [0.92-3.66] p= 0.12 
5-6 20 (19.1%) 18 (17.1%) 1.13 [0.56-2.30] p= 0.86 
7-15 21 (21%) 10 (9.5%) 2.38 [1.06–5.33] p=0.05 
*other neuropsychiatric disorders different from epilepsy 
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